Old Web
English
Sign In
Acemap
>
authorDetail
>
Kazuhide Nakamura
Kazuhide Nakamura
Takeda Pharmaceutical Company
Molecular biology
Biology
Kinase
Cancer research
Cell growth
11
Papers
208
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab
2018
Neoplasia
Hiroya Taniguchi
Yuji Baba
Yoji Sagiya
Masamitsu Gotou
Kazuhide Nakamura
Hiroshi Sawada
Kazunori Yamanaka
Yukiko Sakakibara
Ikuo Mori
Yukiko Hikichi
Junpei Soeda
Hideo Baba
Show All
Source
Cite
Save
Citations (8)
Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine
2017
Molecular Oncology
Yuji Baba
Toshiya Tamura
Yoshihiko Satoh
Masamitsu Gotou
Hiroshi Sawada
Shunsuke Ebara
Kazunori Shibuya
Jumpei Soeda
Kazuhide Nakamura
Show All
Source
Cite
Save
Citations (12)
A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of In Vivo Antitumor Activities
2013
Molecular Cancer Therapeutics
Yoshiko Awazu
Kazuhide Nakamura
Akio Mizutani
Yuichi Kakoi
Hidehisa Iwata
Seiji Yamasaki
Naoki Miyamoto
Shinichi Imamura
Hiroshi Miki
Akira Hori
Show All
Source
Cite
Save
Citations (21)
Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
2013
Bioorganic & Medicinal Chemistry
Shigemitsu Matsumoto
Naoki Miyamoto
Takaharu Hirayama
Hideyuki Oki
Kengo Okada
Michiko Tawada
Hidehisa Iwata
Kazuhide Nakamura
Seiji Yamasaki
Hiroshi Miki
Akira Hori
Shinichi Imamura
Show All
Source
Cite
Save
Citations (37)
1